Details

NameSymbolSector
MANGALAM DRUGS AND ORGANICS LIMITEDMANGALAMPharmaceuticals
Open
72.4
High
73.9
Low
70.6
Close
72.67
Volume
34780
Exchange
nse
Time
03-Oct-2025

Outlook

Score:

2.5

Rating:

RISKY

Candlestick Pattern

CandlepatternofMangalamDrugsAndOrganicsis
High Wave
EstimatedStoplossofMangalamDrugsAndOrganicsis
70.6
MangalamDrugsAndOrganicshasa
Bullishℹ
pattern.
Formationof
High Wave
candlepatternindicatesthetrenddirectionofMangalamDrugsAndOrganicsis
Unpredictableℹ
.

Trend

MangalamDrugsAndOrganicsisin
Sideways trendℹ
.
PriceofMangalamDrugsAndOrganicsis
Downℹ
by

6.27

%.
Target
Buy@

68.05

Sell@

93.39

Current@

72.67

Volume

ThetradevolumesofMangalamDrugsAndOrganicshavebeen
Underperformingℹ
ThevolumetrendforMangalamDrugsAndOrganicsis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofMangalamDrugsAndOrganicsis

Down

by

5.47

%

Valuation

ThecurrentmarketpriceofMangalamDrugsAndOrganicsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth366crandtotalassetsworth366cr,thebalancesheetofMangalamDrugsAndOrganicsis:
Balancedℹ
.
Cashflow
MangalamDrugsAndOrganicshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 1cr

.Itis
Upℹ
by

150

%.
51.22% i.e. ₹ 42cr earned in operatingℹ
23.17% i.e. ₹ 19cr spent in investingℹ
25.61% i.e. ₹ 21cr spent in financingℹ
0% in otherℹ
MangalamDrugsAndOrganicshas
Insufficientℹ
cashflowbecausethereis

Shortage

of

₹ 2cr

.Itis
Downℹ
by

0

%.
15.79% i.e. ₹ 3cr earned in operatingℹ
57.89% i.e. ₹ 11cr spent in investingℹ
26.32% i.e. ₹ 5cr earned in financingℹ
0% in otherℹ
Income
TheincomeofMangalamDrugsAndOrganicsis

₹ 57cr

and

Loss

is:

₹ 13cr

MangalamDrugsAndOrganicsLossesincreasedby:

1300

%andIncomeisDownby:

21.92

%
TheincomeofMangalamDrugsAndOrganicsis

₹ 73cr

and

Loss

is:

₹ 0cr

MangalamDrugsAndOrganicsLossesincreasedby:

100

%andIncomeisDownby:

17.05

%
TheincomeofMangalamDrugsAndOrganicsis

₹ 88cr

and

Profit

is:

₹ 1cr

MangalamDrugsAndOrganicsProfitisdownby:

50

%andIncomeisUpby:

10

%
By using this site you agree to the use of cookies to deliver a better site experience.